An increasing number of Americans are relieved to learn there are non-drug ways to ease pain now that safety questions have been raised about another well-known and widely used painkiller, Bextra.
Recent meetings of the FDA were preceded by a petition from a leading consumer group, Public Citizen, asking that the drug be taken off the market. Both the FDA and Public Citizen raised concerns about the safety of Bextra, one of the so-called Cox-2 inhibitors. The Cox-2 drugs Vioxx and Bextra were once viewed as “wonder drugs” for arthritis and painful menstrual cycles. Legal Steroids Europe
Bextra has moved into the spotlight while the maker of Vioxx is being investigated. Vioxx was one of the nation’s most popular ways to treat pain and arthritis and was taken by an estimated 20 million people before it was withdrawn from the market. That happened after studies linked it to a heightened risk of heart attack and stroke – information that may not have been fully understood when the drugs received FDA approval.
Researchers released information indicating that the chances for heart attack following prolonged use of Vioxx were four times greater than with older over-the-counter pain relievers. It has also been linked to angina and stroke. A University of Pennsylvania study released at a meeting of the American Cardiology Association indicated that those taking Bextra had a 2.19 times greater chance of heart attack, stroke, sudden death and Stevens Johnson Syndrome, a life threatening disorder in which blisters occur on the patient’s body.